Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
| Current Price | ₹25.43 |
|---|---|
| Market Cap | ₹140 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 97.8 |
| Return on Equity | 0.59% |
| 52-Week Range | ₹15.20 – ₹54.94 |
| Beta (1Y) | 1.07 |
| Dividend Yield | 0.00% |
Balaxi Pharmaceuticals Ltd is trading at ₹25.43, with a market capitalisation of ₹140 Cr.
Balaxi Pharmaceuticals Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Balaxi Pharmaceuticals Ltd has a P/E of 97.8 and a return on equity of 0.59%.